Skip to main content
Clinical Trials/NCT05197972
NCT05197972
Recruiting
Not Applicable

Phase III Study Evaluating a Non-drug Intervention (NDI) Program by Fixed-frequency Guided Breathing (Cardiac Coherence) Associated With Medical Hypnosis on Preoperative Anxiety in Oncological Surgery

Institut du Cancer de Montpellier - Val d'Aurelle4 sites in 1 country296 target enrollmentJune 1, 2022
ConditionsSurgeryOncology

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Surgery
Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Enrollment
296
Locations
4
Primary Endpoint
Visual Analogue Scale (VAS) of global anxiety
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The investigator proposes to use the cardiac coherence technique (Cardiac Coherence) coupled with a hypnosis session to reduce pre-operative anxiety.

Detailed Description

The perioperative period is recognized as anxiety-provoking for most patients. In oncology, 60 to 80% of patients suffer from stress throughout their treatment. If for some patients, this anxiety is more or less manageable, for others, it is the major concern with regard to their intervention. For many years, pharmacological premedication, especially with benzodiazepines, has been the gold standard for the treatment of preoperative anxiety, but this systematic prescription is increasingly controversial, especially in populations most exposed to side effects, such as elderly subjects and patients with cardiac or respiratory pathologies. The aim of this study is to propose an alternative to pharmacological premedication by a non-drug approach. The two techniques (the Fixed Rate Guided Breathing Technique = cardiac coherence and hypnosis) can potentiate each other and become synergistic. Thus, for patients undergoing oncological surgery, regular practice of cardiac coherence coupled with hypnosis prior to their surgery should enable them to better manage perioperative anxiety and thus significantly reduce their level of anxiety on the day of their surgery. The association of the 2 techniques combines several advantages: * It is totally "physiological", free and immediately available for the patient and without any undesirable effect; * It gives autonomy to the patient to manage his stress, making him independent of chemical molecules, the presence of a third party or expensive equipment. * It will allow oncology patients to use it throughout their care (invasive examinations, MRI imaging, heavy and complex care such as certain dressings, etc.) This work will allow: * To give oncology patients the possibility to be actors of their care by a self-management of their anxiety in substitution or complement of a medicated approach; * To map anxiety in oncology surgery using a simple scale such as the EVA, which has not yet been done; * To identify the most anxious patients in order to provide them with the appropriate management (pharmacological and/or NMI) before their surgery; * To evaluate the correlation between the level of preoperative anxiety and the occurrence of postoperative adverse events; * To evaluate the correlation between the level of anxiety and the quality of recovery (QoR) and the postoperative experience (EVAN-G). Patients in the experimental group will be interviewed to explain how to perform the cardiac coherence and hypnosis sessions at home before the surgery.

Registry
clinicaltrials.gov
Start Date
June 1, 2022
End Date
December 2026
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age ≥ 18 years old
  • Patient with a scheduled surgery for a cancer (suspected or declared) with a classic or ambulatory hospitalization
  • Patients requiring general anesthesia with or without associated loco-regional anesthesia or loco-regional anesthesia alone
  • Patient with a smartphone or a tablet or a computer and able to install the application
  • Inclusion of the patient minimum 7 days before the date of the surgery
  • Patient who signed the informed consent
  • Patient affiliated to a French social security system

Exclusion Criteria

  • Emergency surgery
  • Plastic surgery for reconstruction: lipomodelling
  • Prophylactic surgery: no suspected or existing cancer
  • Bradycardia (\< 50 beats/minute) with β-blockers
  • Severe heart failure with ventricular ejection fraction \< 40%
  • Uncontrolled chronic pain for more than three months on morphine
  • Patient with unstable epilepsy or respiratory pathology with rest dyspnea
  • Patient used to and having a regular and habitual practice of relaxation techniques such as yoga, hypnosis, sophrology, meditation, music therapy, virtual reality, ...
  • Medical (neurological, psychiatric, etc.) or psychological conditions not allow for participation in the protocol (completion of questionnaires and booklet, compliance with the cardiac coherence program coupled with hypnosis)
  • Deaf patient without hearing aids

Outcomes

Primary Outcomes

Visual Analogue Scale (VAS) of global anxiety

Time Frame: The morning of the surgery (Day 0) upon arrival in the operating room

Visual Analogue Scale (VAS) of global anxiety is a anxiety self-assessment scale that allows the patient to self-assess his or her anxiety using a cursor. The scale ranges from 0 (no anxiety) to 100 (maximum anxiety).

Secondary Outcomes

  • Measurement of global and specific anxiety level by using a Visual Analogue Scale (VAS)(Between -15 to -7 days before surgery (Day -15 to Day -7))
  • Doses of hypnotic and morphine drugs(During anesthetic induction (Day 0))
  • Evaluation of the Vecu of General Anesthesia questionnaire (EVAN-G)(Two day after surgery (Day 2))
  • Visual Analogue Scale (VAS) of pain(At 1, 2 and 3 month after surgery)
  • Quality of Recovery (QoR)(The day after surgery (Day 1))
  • Insomnia Severity Index Scale (ISI)(The day after surgery (Day 1))
  • VAS of on satisfaction with overall management and anesthesia(The day after surgery (Day 1))
  • Value of preoperative VAS and adverse events(The morning of the surgery (Day 0) upon arrival in the operating room)
  • Number of Self-questionnaire completed(From the day of the anesthesia consultation until the end of the study)
  • Program compliance(Between -15 to -7 days before surgery (Day -15 to Day -7) until the day of surgery (Day 0))
  • Number of patients taking benzodiazepine(The day after surgery (Day 1))
  • Measurement of global anxiety level by using a Visual Analogue Scale (VAS)(Between -15 to -7 days before surgery and the day of surgery (Day 0))
  • The preoperative anxiety score by using the Amsterdam Preoperative Anxiety and Information Scale (APAIS)(Between -15 to -7 days before surgery)
  • VAS values and individual psycho-clinical characteristics(Between -15 to -7 days before surgery and the day of surgery (Day 0))
  • Number of days of hospitalization(The day after surgery (Day -1) and up to 1 month)
  • VAS values and mode of hospitalization and importance of the surgical procedure(The morning of the surgery (Day 0) upon arrival in the operating room)

Study Sites (4)

Loading locations...

Similar Trials